The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Cells · 19.02.2025 · 14 (4) · 309
DOI: 10.3390/cells14040309 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 19.02.2025. Verfasst von Liyun Lin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunogenetics, Department of Medical Sciences, University of Turin, 10126 Turin, Italy. Hauptthemen laut MEDLINE: 5'-Nucleotidase, Adenosine, Apyrase, Lymphoma, T-Cell, Cutaneous. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Projects of National Relevant Interest, Swiss National Science Foundation, China Scholarship Council.
Abstract (Originalsprache)
Cutaneous T-cell lymphoma (CTCL), characterized by malignant T-cell proliferation primarily in the skin, includes subtypes such as mycosis fungoides (MF) and Sézary syndrome (SS). The tumor microenvironment (TME) is central to their pathogenesis, with flow cytometry and histology being the gold standards for detecting malignant T cells within the TME. Alongside emerging molecular markers, particularly clonality analysis, these tools are indispensable for accurate diagnosis and treatment planning. Of note, adenosine signaling within the TME has been shown to suppress immune responses, affecting various cell types. The expression of CD39, CD73, and CD38, enzymes involved in adenosine production, can be elevated in MF and SS, contributing to immune suppression. Conversely, the expression of CD26, part of the adenosine deaminase/CD26 complex, that degrades adenosine, is often lost by circulating tumoral cells. Flow cytometry has demonstrated increased levels of CD39 and CD73 on Sézary cells, correlating with disease progression and prognosis, while CD38 shows a variable expression, with its prognostic significance remaining under investigation. Understanding these markers’ roles in the complexity of TME-mediated immune evasion mechanisms might enhance diagnostic precision and offer new therapeutic targets in CTCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunogenetics, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
- Section of Dermatology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
- Pathology Unit, Department of Oncology, University of Turin, 10126 Turin, Italy.
- Dermatology Department, Saint-Louis Hospital, AP-HP, Université Paris Cité, Inserm U976, 75010 Paris, France.
- Department of Pathology, Hôpital Saint-Louis, AP-HP, Université Paris Cité, Inserm U976, 75010 Paris, France.
- Department of Dermatology, Lausanne University Hospital (CHUV) and Faculty of Biology and Medicine, University of Lausanne, 1007 Lausanne, Switzerland.
ORCID-Profile: Gabriele Roccuzzo, Yuliya Yakymiv, Erika Ortolan, Ada Funaro, Rebecca Senetta, Valentina Pala, Adèle de Masson, Maxime Battistella, Emmanuella Guenova, Simone Ribero
Förderung
- Research Projects of National Relevant Interest
- Swiss National Science Foundation
- China Scholarship Council
Zitieren
APA
Lin, L., Roccuzzo, G., Yakymiv, Y., Marchisio, S., Ortolan, E., Funaro, A., Senetta, R., Pala, V., Bagot, M., de Masson, A., Battistella, M., Guenova, E., Ribero, S., & Quaglino, P. (2025). The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas. Cells, 14(4), 309. https://doi.org/10.3390/cells14040309
Vancouver
Lin L, Roccuzzo G, Yakymiv Y, Marchisio S, Ortolan E, Funaro A, et al. The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas. Cells. 2025;14(4):309. doi:10.3390/cells14040309
BibTeX
@article{Lin2025,
author = {Lin, Liyun and Roccuzzo, Gabriele and Yakymiv, Yuliya and Marchisio, Sara and Ortolan, Erika and Funaro, Ada and Senetta, Rebecca and Pala, Valentina and Bagot, Martine and de Masson, Adèle and Battistella, Maxime and Guenova, Emmanuella and Ribero, Simone and Quaglino, Pietro},
title = {The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas},
journal = {Cells},
year = {2025},
volume = {14},
number = {4},
pages = {309},
doi = {10.3390/cells14040309}
}
EUVIMED